Get notified when COAG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsHemab Therapeutics board member Laura Tadvalkar resigns effective immediately
Filed May 11, 2026 · Period ending May 8, 2026 · ~1 min read
Key Changes
-
medium
Dr. Laura Tadvalkar resigned from the Board of Directors effective May 8, 2026, with the company stating the departure was not due to any disagreement on operations, policies, or practices.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade COAG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify